The Zhongshan Institute for Drug Discovery (Center for Drug Safety Evaluation and Research) has passed an on-site inspection by the National Medical Products Administration (NMPA) and received the drug GLP (Good Laboratory Practice) certificate.

The certification covers core areas of non-clinical drug safety evaluation. It confirms ZIDD's full compliance with GLP standards in facility and equipment, staff qualifications and training, study design and technical procedures, and quality control and reporting. A systematic and robust quality management system for drug safety evaluation is now firmly in place.

Going forward, ZIDD will continue strengthening its quality system and aligning with international GLP benchmarks, including those of the US Food and Drug Administration and the Organisation for Economic Cooperation and Development. The goal is to expand non-clinical safety evaluation capacity for diversified, complex formulations and innovative drugs.